stockrowArdelyx, Inc. (ARDX) vs Prime Medicine, Inc. (PRME)
- Ardelyx, Inc. ARDX 2.86 −4.35%
- Prime Medicine, Inc. PRME 4.61 +3.60%
Ardelyx, Inc. and Prime Medicine, Inc. are both Biotechnology companies. Ardelyx, Inc. and Prime Medicine, Inc. are of similar size ($807.1M and $751.6M). Ardelyx, Inc. grew revenue faster over the last twelve months: 17.6% against −17.9%. Ardelyx, Inc. has the higher net margin (−11.9% vs −4,613.1%) and the lower return on invested capital (−17.2% vs 0.00%). Across the 17 metrics below, Ardelyx, Inc. leads on 12 and Prime Medicine, Inc. on 5.
Valuation
Profitability
| Metric | ARDX | PRME | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.46% | 100.00% | 68.51% |
| Operating margin | (7.71%) | (4,824.94%) | 0.00% |
| Net margin | (11.85%) | (4,613.11%) | 0.00% |
| Free cash flow margin | (3.41%) | (3,850.92%) | 0.00% |
| Return on equity | (34.85%) | (373.29%) | (51.96%) |
| Return on assets | (10.33%) | (71.16%) | (46.06%) |
| Return on invested capital | (17.21%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack